Literature DB >> 21084260

Neonatal experiences differentially influence mammary gland morphology, estrogen receptor {α} protein levels, and carcinogenesis in BALB/c mice.

Allison L Boyd1, Ayesha Salleh, Brent Humber, Janet Yee, Ladislav Tomes, Leslie R Kerr.   

Abstract

Prevention of breast cancer can be achieved with a better understanding of the factors contributing to normal breast development. Because the breast develops postnatally, alterations in the development and lifetime activity of the neuroendocrine system may set up an environment that increases cancer risk. The present study examined how two neonatal experiences over the first 3 weeks of life influence normal and malignant mammary gland development in female BALB/c mice. Following puberty, both brief (15 minutes) and prolonged (4 hours) daily maternal separations of newborn mice accelerated mammary gland development relative to nonseparated mice. Despite similar mammary gland morphologies between mice exposed to these two neonatal separation experiences, only mice exposed to prolonged maternal separation bouts showed a higher incidence and faster onset of mammary tumorigenesis following adulthood carcinogen [7,12-dimethylbenz(a)anthracene] administration. Molecular analysis of estrogen receptor α (ERα) and p53, two proteins that have been implicated in breast cancer, revealed that for mice exposed to prolonged neonatal maternal separation bouts, mammary gland ERα protein levels were upregulated in a transcription-independent manner. On the other hand, p53 expression in mammary glands of adult mice was not differentially influenced by neonatal experiences. Our findings show that chronic, moderate psychosocial stress during the neonatal period increases the expression of ERα protein and promotes mammary tumorigenesis in adulthood. ©2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21084260     DOI: 10.1158/1940-6207.CAPR-10-0111

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  7 in total

Review 1.  Molecular pathways: beta-adrenergic signaling in cancer.

Authors:  Steven W Cole; Anil K Sood
Journal:  Clin Cancer Res       Date:  2011-12-20       Impact factor: 12.531

2.  A Novel Effect of β-Adrenergic Receptor on Mammary Branching Morphogenesis and its Possible Implications in Breast Cancer.

Authors:  Lucía Gargiulo; María May; Ezequiel M Rivero; Sabrina Copsel; Caroline Lamb; John Lydon; Carlos Davio; Claudia Lanari; Isabel A Lüthy; Ariana Bruzzone
Journal:  J Mammary Gland Biol Neoplasia       Date:  2017-01-11       Impact factor: 2.673

3.  Psychosocially influenced cancer: diverse early-life stress experiences and links to breast cancer.

Authors:  Linda A Schuler; Anthony P Auger
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-07

4.  Chronic social isolation is associated with metabolic gene expression changes specific to mammary adipose tissue.

Authors:  Paul A Volden; Erin L Wonder; Maxwell N Skor; Christopher M Carmean; Feenalie N Patel; Honggang Ye; Masha Kocherginsky; Martha K McClintock; Matthew J Brady; Suzanne D Conzen
Journal:  Cancer Prev Res (Phila)       Date:  2013-06-18

5.  Effects of enriched environment on COX-2, leptin and eicosanoids in a mouse model of breast cancer.

Authors:  Rachida Nachat-Kappes; Alexandre Pinel; Kristell Combe; Bruno Lamas; Marie-Chantal Farges; Adrien Rossary; Nicolas Goncalves-Mendes; Florence Caldefie-Chezet; Marie-Paule Vasson; Samar Basu
Journal:  PLoS One       Date:  2012-12-13       Impact factor: 3.240

6.  Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients.

Authors:  Hitesh N Appaiah; Chirayu P Goswami; Lida A Mina; Sunil Badve; George W Sledge; Yunlong Liu; Harikrishna Nakshatri
Journal:  Breast Cancer Res       Date:  2011-09-13       Impact factor: 6.466

7.  CARM1 automethylation is controlled at the level of alternative splicing.

Authors:  Lu Wang; Purin Charoensuksai; Nikole J Watson; Xing Wang; Zibo Zhao; Carlos G Coriano; Leslie R Kerr; Wei Xu
Journal:  Nucleic Acids Res       Date:  2013-05-30       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.